Collateral damage: the conundrum of drug safety

被引：23

作者：

Gale, E. A. M. ^{[1
]}

机构：

[1] Southmead Hosp, Med Sch Unit, Bristol BS10 5NB, Avon, England

来源：

DIABETOLOGIA | 2009年 / 52卷 / 10期

关键词：

Diabetes; Diabetes therapies; Drug safety; Exenatide; Pharmacovigilance; ACUTE-PANCREATITIS; EXENATIDE; RISK;

D O I：

10.1007/s00125-009-1491-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1975 / 1982

页数：8

相关论文

共 35 条

[1] AHMED SR, 2008, NEW ENGL J MED, V358, P1969
[2] [Anonymous], 2016, ATHENS J LAW, DOI DOI 10.30958/AJL.2-2-2
[3] Exenatide and pancreatitis: an update
Bain, Steve C.
Stephens, Jeffrey W.
[J]. EXPERT OPINION ON DRUG SAFETY, 2008, 7 (06) : 643 - 644
[4] *COMM ASS US DRUG, 2007, FUT DRUG SAF
[5] Exenatide (Exendin-4)-induced pancreatitis - A case report
Denker, PS
Dimarco, PE
[J]. DIABETES CARE, 2006, 29 (02) : 471 - 471
[6] Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide
Dore, David D.
Seeger, John D.
Chan, K. Arnold
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (04) : 1019 - 1027
[7] Galbraith J.K., 1993, American capitalism: The concept of countervailing power
[8] A drug on the market?
Gale, EAM
Clark, A
[J]. LANCET, 2000, 355 (9197) : 61 - 63
[9] The Hawthorne studies - a fable for our times?
Gale, EAM
[J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2004, 97 (07) : 439 - 449
[10] Troglitazone: the lesson that nobody learned?
Gale, EAM
[J]. DIABETOLOGIA, 2006, 49 (01) : 1 - 6

← 1 2 3 4 →